Similar articles for PMID: 15483312

Year	Number of Results
1988	1
1989	1
1990	3
1991	1
1992	2
1993	2
1994	12
1995	10
1996	13
1997	14
1998	16
1999	13
2000	15
2001	8
2002	7
2003	13
2004	14
2005	14
2006	16
2007	17
2008	11
2009	7
2010	8
2011	11
2012	10
2013	8
2014	6
2015	5
2016	3
2017	3
2018	3
2019	4
2020	2
2024	0

1

Gender differences in progression to AIDS and death from HIV seroconversion in a cohort of injecting drug users from 1986 to 2001.

García de la Hera M, Ferreros I, del Amo J, García de Olalla P, Pérez Hoyos S, Muga R, del Romero J, Guerrero R, Hernández-Aguado I; GEMES. García de la Hera M, et al. J Epidemiol Community Health. 2004 Nov;58(11):944-50. doi: 10.1136/jech.2003.017475. J Epidemiol Community Health. 2004. PMID: 15483312 Free PMC article.

2

Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART.

Jarrin I, Lumbreras B, Ferreros I, Pérez-Hoyos S, Hurtado I, Hernández-Aguado I. Jarrin I, et al. Int J Epidemiol. 2007 Feb;36(1):187-94. doi: 10.1093/ije/dyl231. Epub 2006 Nov 3. Int J Epidemiol. 2007. PMID: 17085455

3

[Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART)].

Pezzotti P, Dorrucci M, Donisi A, Cusini M, Mazzarello G, De Luca A, Salassa B, Ursitti MA, Giuliani M, Rezza G; l'Italian Seroconversion Study. Pezzotti P, et al. Epidemiol Prev. 2003 Nov-Dec;27(6):348-55. Epidemiol Prev. 2003. PMID: 15058363 Italian.

4

Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.

[No authors listed] [No authors listed] AIDS. 1994 Jul;8(7):911-21. AIDS. 1994. PMID: 7946100

5

Survival and progression to AIDS in a seroconverter cohort in the post-highly active antiretroviral therapy era: effectiveness goes on.

Pérez-Hoyos S, Ferreros I, del Amo J, Muga R, del Romero J, de Olalla PG, Hernández-Aguado I. Pérez-Hoyos S, et al. AIDS. 2006 Jan 9;20(2):289-91. doi: 10.1097/01.aids.0000202651.41397.db. AIDS. 2006. PMID: 16511426

6

[Mortality in a cohort of intravenous drug users before the introduction of potent HIV therapy].

Muga R, Egea JM, Navío M, Sirera G, Vall M, Tor J. Muga R, et al. Med Clin (Barc). 1999 May 29;112(19):721-5. Med Clin (Barc). 1999. PMID: 10394568 Spanish.

7

Changes in the incidence of tuberculosis in a cohort of HIV-seroconverters before and after the introduction of HAART.

Muga R, Ferreros I, Langohr K, de Olalla PG, Del Romero J, Quintana M, Alastrue I, Belda J, Tor J, Pérez-Hoyos S, Del Amo J; Spanish Multicenter Study Group of Seroconverters (GEMES). Muga R, et al. AIDS. 2007 Nov 30;21(18):2521-7. doi: 10.1097/QAD.0b013e3282f1c933. AIDS. 2007. PMID: 18025889

8

Mortality is influenced by locality in a major HIV/AIDS epidemic.

Druyts EF, Rachlis BS, Lima VD, Harvard SS, Zhang W, Brandson EK, Strathdee SA, Montaner JS, Hogg RS. Druyts EF, et al. HIV Med. 2009 May;10(5):274-81. doi: 10.1111/j.1468-1293.2008.00684.x. Epub 2009 Feb 5. HIV Med. 2009. PMID: 19210694 Free article.

9

Race, sex, drug use, and progression of human immunodeficiency virus disease.

Chaisson RE, Keruly JC, Moore RD. Chaisson RE, et al. N Engl J Med. 1995 Sep 21;333(12):751-6. doi: 10.1056/NEJM199509213331202. N Engl J Med. 1995. PMID: 7643881 Free article.

10

Impact of injecting drug use on mortality in Danish HIV-infected patients: a nation-wide population-based cohort study.

Larsen MV, Omland LH, Gerstoft J, Larsen CS, Jensen J, Obel N, Kronborg G. Larsen MV, et al. Addiction. 2010 Mar;105(3):529-35. doi: 10.1111/j.1360-0443.2009.02827.x. Addiction. 2010. PMID: 20402997

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

259 results

Results by year